Efficacy of Low-dose Bisoprolol in Maintenance Hemodialysis Patients with Asymptomatic Left Ventricular Diastolic Dysfunction  by Shen, Wei et al.
S120 Dialysis0105
Effect and Mechanism of Tamoxifen on Peritoneal Fibrosis in Mice
Undergoing Peritoneal Dialysis
Xiang Zhao
Zhejiang Province People’s Hospital, Hangzhou, Zhejiang, China
Objective: To investigate the effect and the perhaps mechanism of tamox-
ifen on peritoneal dialysis related peritoneal fibrosis.
Methods: Intraperitoneal injected with 4.25% glucose peritoneal dialysis
fluid to establish a mouse model of peritoneal fibrosis. C57BL/6 male mouse
were randomly divided into three groups: control group; high-glucose perito-
neal fluid group (PDF group), and tamoxifen group (TAX group). Histologic
changes were examined by Masson’s trichrome stain. Expression of Wnt4,
b-catenin, E-cadherin, NF-kB, COL1A1, cytokeratin protein were evaluated
by immunofluorescence staining and Western Blot.
Results: A light microscope Masson’s trichrome stain showed the peritonum
of mouse in PDF group are significantly thicker than control group; the
tamoxifen treatment ameliorated the thickening of peritoneum induced by
PDF. Immunofluorescence staining and Western Blot showed that protein
expression of Wnt4, b-catenin, NK-kB, COL1A1 increased in PDF group than
in control group (all P < 0.05), protein expression of E-cadherin and basic
cytokeratin decreased in PDF group than in control group (all P < 0.05).
The tamoxifen treatment ameliorated the increased expression of Wnt4,
b-catenin, NK-kB, COL1A1 induced by PDF and the expression of E-cadherin
and basic cytokeratin decreased than in PDF group.
Conclusion: Peritoneal dialysis related peritoneal fibrosis may mediated by
the activation of Wnt / b-catenin signaling pathway in mouse peritonum, and
tamoxifen can ameliorated peritoneal fibrosis possibly by inhibiting the Wnt
/ b-catenin signaling pathway.http://dx.doi.org/10.1016/j.hkjn.2015.09.180
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Efficacy of Low-dose Bisoprolol in Maintenance Hemodialysis Patients
with Asymptomatic Left Ventricular Diastolic Dysfunction
Wei Shen, Qiang He, Yiwen Li
Kidney Disease Center, Zhejiang Province People’s Hospital, Hangzhou,
Zhejiang, China
Objective: Left ventricular hypertrophy and diastolic dysfunction are the most
frequent cardiac alteration in ESRD. The aim of this study was to determine
whether the b-blocker, bisoprolol, has beneficial effects inmaintenance hemo-
dialysis patients with asymptomatic left ventricular diastolic dysfunction.
Methods: In this study we enrolled 120 patients with chronic kidney disease
(CKD) undergoingmaintenancehemodialysis accompanying left ventricular dia-
stolic dysfunction more than six months. Bisoprolol was started with 1.25 mg
once daily orally 30 minutes after breakfast and increased every 1 week by
1.25 mg increments up to the maximum tolerated dose. Echocardiographic ex-
amination was used to measurement of left ventricular diastolic function.
Results: 108 patients finished 6 months study. After 6 months of treatment,
compared with the baseline, the cardiothoracic ratio was significant
decreased. Echocardiographic examination showed that there was no signif-
icant change in EF, but LVDd, LVDs, PWT were significant decreased. E/A ra-
tio was significantly increased.
Conclusion: Our study demonstrate bisoprolol efficacy in improving left ven-
tricular diastolic dysfunction in HD patient with normal blood pressure.http://dx.doi.org/10.1016/j.hkjn.2015.09.1810109
Effect of Hemodialysis on Anterior Chamber Biometric Structure and
Intraocular Pressure in Non-Diabetic Patients with End-stage Renal
Disease
Wei Shen, Qiang He, Yiwen Li
Kidney Disease Center, Zhejiang Province People’s Hospital, Hangzhou,
Zhejiang, China
Objective: To evaluate the short-term changes in the ophthalmologic find-
ings after low-flux hemodialysis in non-diabetic end-stage chronic renal fail-
ure (CRF) patients.
Methods: Forty-three patients (86 eyes) selected so as not to have glaucoma or
history of glaucomawere studied. We observed the patients onmaintenance he-
modialysis therapymore than6months. Their clinical characteristics andmedical
recordsbeforeandafterhemodialysiswere reviewedthroughthewayof self-con-
trol study. Detailed ophthalmologic examinations together with tomometre
(intraocular pressure, IOP), A/B scan (lens thickness) and ultrasound bio-
microscopy (central anterior chamber depth) were performed immediately
beforeandafterHDsessions.Demographic information includingage, gender,un-
derling systemicdiseases,hemodialysisduration,and levelsofbodyweight,blood
urea nitrogen, and creatinine before and after hemodialysis were recorded.
Results: The mean age of the patients at the time of dialysis was 49.7 12.0
(range 33 to 65) years. 53.5% (23) were men. After hemodialysis treatment,
the blood urea nitrogen, creatinine, patient weight decreased significantly
(P < 0.01). There was no significant difference in the change in serum cal-
cium, serum phosphorus, serum albumin and hemoglobin after treatment
(P > 0.05). Mean central anterior chamber depth also decreased significantly
after HD, from 2.46 0.38 to 2.38 0.36 mum (paired t test, P < 0.01).
Mean lens thickness significantly increased from 4.23 0.22 mm before HD
to 4.30 0.12 mm after HD (P < 0.01) in group. However, Mean IOP
increased from 12.32 4.31 mmHg to 14.31 2.98 mmHg after HD (paired
t test, P < 0.01).
Conclusion:Conventional hemodialysis can affect the ophthalmologic findings.
Patients with chronic renal failure should be checked of their anterior chamber
structure and be given corresponding treatment before haemodialysis.http://dx.doi.org/10.1016/j.hkjn.2015.09.182
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miRNA-143/145 Gene Cluster Enhances Cell Deformation and Fibrosis of
Human Peritoneal Mesothelial Cells via Modulating TPM4
Lijie He, Jinping Hu, Tiantian Shi
Department of Nephrology, Xi’an, China
Objective: This work for the function and mechanism of miR-143/145 gene
cluster in human peritoneal mesothelial cells (HPMC).
Methods: To investigate if miR-143/145 gene cluster could promote PM
fibrosis, all these immortal and cast-off HPMCs from the effluents of
end-stage renal disease (ESRD) patients with peritoneal dialysis (PD)
were characterized by fibrosis related markers and tested the expression
of miRNA-143/145 cluster and tropomyosin 4 (TPM4) by real time PCR or
Western blot. We also used PD dialysis rat model to observe the response
of PM to miR-143/145 gene cluster and their possible target.
Results: Here, we found that miR-143/145 gene cluster, which are exam-
ined to be highly expressed in HG-induced HPMCs or in cast-off HPMCs ex
vivo which have a transformed fibroblastic phenotype stimulated by high
glucose (HG, 60 mmol/L) and in PD animal model. TPM4 were found signif-
icantly lower expression in HG-induced HPMCs. So our study showed that
high glucose from PD fluid could promote the expression of miR-143/145
of HPMCs and reduce the expression of TPM4, compared with normal
glucose-cultured HPMCs (Figure 1A-E). Reporter assays further supported
that TPM4 were post-transcriptionally regulated together by miR-143/145
gene cluster. Collectively, these data suggested that TPM4 was a down-
stream target of miR-143/145 gene cluster. Re-expression of miR-143/
145 gene cluster by miR-143 or miR-145 mimic led to cell deformation,
and reduced cell adhesion, following the down-regulating expression of
TPM4 and E-cadherin, but up-regulating expression of a-SMA, CTGF, colla-
gens and fibronectin which might increase PM fibrosis. Depletion of miR-
143/145 cluster in HG-induced HPMCs enhanced cell adhesion, marking
by up-regulating E-cadherin and TPM4 but down-regulating a-SMA, CTGF,
collagens and fibronectin in vitro (Figure 1F).
